Skip to content

Home
About
Our Products & Services
Our Team
Get Started
Podcasts
- Improbable Developments
- Raising Rare
Resources

Empowering patients to shape the future of medicine™

For Patients & Care Partners

Posts Tagged ‘HR5247’

Who would Vote Against Patients’ Right to Try?

By Kevin Freiert | March 31, 2018 | 0

http://bit.ly/NoR2T

0 Shares

Recent Posts

The Shortest Timeline to a COVID Vaccine
Carol Marzetta: Living to Help Other People
Salem Oaks and The Friedreich’s Ataxia Research Alliance Are Partnering on Course on Clinical Trial Protocols
Looking Back at Our Growth in 2019
Donald Kirsch: Getting to Know a Drug Hunter

Archives

September 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
January 2019
December 2018
November 2018
October 2018
September 2018
June 2018
May 2018
March 2018
January 2018
October 2017
September 2017

Tags

2019 art Aspirations barriers caregivers Change clinical trial conferences courage Decision-making disease drug development Drug dicovery drug discovery FARA Friedreich's Ataxia funding decisions Global Genes growth hope HR5247 Improbable Developments motivation patient-centric patient advocates patient education patient engagement patient engagement strategy Pharmaceuticals photography Plans podcast Policy power Pre-Clinical Research progress rare disease rare diseases Research Team Right to Try Salem Oaks Reaching High storytelling Toxicology UPenn urgency

Privacy Policy Terms & Conditions

Awards_Collaborator - Finalist_no background

Salem-Oaks-for-Web

Get In Touch!

1-860-917-8917

216 Beckwith Hill Dr, Salem, CT 06420

office@salemoaks.com

© 2020 Salem Oaks. All Rights Reserved.